Tighter oversight of promotional strategies
A., Pfeifer, M
The most defensible summary is that tirzepatide is the evidence-complete option available today, and retatrutide is the higher-ceiling candidate whose full value and full risk profile will only be known when its phase 3 program is published, scrutinized, and, if warranted, translated into an approval and a label
Engage in Regular Physical Activity Even if youre not lifting weights, maintaining an active lifestyle through walking, yoga, or bodyweight exercises can help minimize muscle loss
The choice between semaglutide and tirzepatide often comes down to effectiveness goals versus cost considerations
Care in hours, not months, designed to scale without compromise: The average wait time to see an obesity medicine specialist in the U.S